# Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery (HAEMOVAX)

> **NCT07699016** · — · RECRUITING · sponsor: **University of Milan** · enrollment: 15 (estimated)

## Conditions studied

- Hemostasis
- Perioperative Bleeding
- Cardiovascular Surgery
- Cardiac Surgery
- Vascular Surgery

## Interventions

- **OTHER:** observational study

## Key facts

- **NCT ID:** NCT07699016
- **Lead sponsor:** University of Milan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-07-16
- **Final completion:** 2026-08-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699016, "Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery (HAEMOVAX)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07699016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*